Biohaven Pharmaceutical Holding Stock Technical Analysis
| BHVN Stock | USD 45.23 0.36 0.79% |
As of the 26th of November, Biohaven Pharmaceutical shows the Risk Adjusted Performance of 0.0543, mean deviation of 2.47, and Downside Deviation of 2.61. Biohaven Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biohaven Pharmaceutical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biohaven, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiohavenBiohaven |
Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biohaven Pharmaceutical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biohaven Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Biohaven Pharmaceutical Trend Analysis
Use this graph to draw trend lines for Biohaven Pharmaceutical Holding. You can use it to identify possible trend reversals for Biohaven Pharmaceutical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Biohaven Pharmaceutical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Biohaven Pharmaceutical Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Biohaven Pharmaceutical Holding applied against its price change over selected period. The best fit line has a slop of 0.19 , which means Biohaven Pharmaceutical Holding will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1352.9, which is the sum of squared deviations for the predicted Biohaven Pharmaceutical price change compared to its average price change.About Biohaven Pharmaceutical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biohaven Pharmaceutical Holding on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biohaven Pharmaceutical Holding based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biohaven Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Biohaven Pharmaceutical. By analyzing Biohaven Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biohaven Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biohaven Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
Biohaven Pharmaceutical November 26, 2024 Technical Indicators
Most technical analysis of Biohaven help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biohaven from various momentum indicators to cycle indicators. When you analyze Biohaven charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0543 | |||
| Market Risk Adjusted Performance | 0.2428 | |||
| Mean Deviation | 2.47 | |||
| Semi Deviation | 2.46 | |||
| Downside Deviation | 2.61 | |||
| Coefficient Of Variation | 1644.51 | |||
| Standard Deviation | 3.55 | |||
| Variance | 12.57 | |||
| Information Ratio | 0.0245 | |||
| Jensen Alpha | 0.1008 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0333 | |||
| Treynor Ratio | 0.2328 | |||
| Maximum Drawdown | 22.52 | |||
| Value At Risk | (3.90) | |||
| Potential Upside | 6.52 | |||
| Downside Variance | 6.82 | |||
| Semi Variance | 6.05 | |||
| Expected Short fall | (3.09) | |||
| Skewness | 1.37 | |||
| Kurtosis | 4.02 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.